Investor Relations
Mar 23, 2018
OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes MORE >>
Mar 16, 2018
OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology MORE >>
Mar 01, 2018
OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results MORE >>
Feb 26, 2018
OPKO Health to Announce Fourth Quarter and Year End 2017 Financial Results on March 1, 2018 MORE >>

Investor FAQs

Show All
When was OPKO Health founded?

OPKO Health was incorporated in Delaware in 1991 as Cytoclonal Pharmaceutics, Inc.


When will OPKO Health, Inc. next report financial results?

The company expects to report financial results for the fourth quarter 2017 and the year 2017 in February, 2018. No specific day yet selected.

Where are OPKO Health's shares traded?

OPKO Health common stock is traded on the New York Stock Exchange under the symbol “OPK.”

Where can I find OPKO Health, Inc.'s latest investor presentation?

The company’s most recent investor presentation is available in the “Investors” section on the company’s website. It can also be accessed at the “Events” page of the “Investors” section on the company’s website.

When is OPKO Health, Inc.'s fiscal year end?

The fiscal year ends on December 31.

Has OPKO Health, Inc. ever had a stock split?


Can I buy OPKO Health stock directly from the company?

OPKO Health does not offer a direct stock purchase plan. Shares of the company can be purchased through a brokerage company.

Does OPKO Health, Inc. issue dividends on its common stock?

OPKO Health, Inc. has never declared or paid cash dividends. The company intends to retain any future earnings for the operation and expansion of its business and does not anticipate paying any cash dividends in the foreseeable future.

When is OPKO Health, Inc.'s Annual Meeting of Stockholders?

The date and location will be published in the company’s proxy statement, which can be found on the “SEC Filings” section in the “Investors” section on the company’s website.

Where are OPKO Health, Inc.'s headquarters?

OPKO Health Corporate Headquarters
4400 Biscayne Blvd.

Miami, FL 33137

Tel: (305) 575-4100

Who is OPKO Health's transfer agent?

American Stock Transfer & Trust Company, LLC,

6201 15th Ave.

Brooklyn, NY 11209
Toll-free at (877) 248-6417 or

(718) 921-8317

Who do I contact about replacement of stock certificates?

To replace lost stock certificates, please contact OPKO Health’s transfer agent

Who should shareholders notify of a change in address?

To change your address, please contact OPKO Health’s transfer agent.

Where can former shareholders of Bio-Reference Laboratories, Inc. have questions answered related to the exchange of BRLI shares for OPK shares?

For questions related to the exchange of BRLI shares for OPK shares, please contact OPKO Health’s transfer agent.